Uri Kopylov

Research interests

Publications

• ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

  Journal of Crohn s and Colitis · 2024 · https://doi.org/10.1093/ecco-jcc/jjae091

• ECCO Guidelines on Inflammatory Bowel Disease and Malignancies

  Journal of Crohn s and Colitis · 2022 · https://doi.org/10.1093/ecco-jcc/jjac187

• ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment

  Journal of Crohn s and Colitis · 2021 · https://doi.org/10.1093/ecco-jcc/jjab177

• ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

  Journal of Crohn s and Colitis · 2021 · https://doi.org/10.1093/ecco-jcc/jjab178

• Deep learning for wireless capsule endoscopy: a systematic review and meta-analysis

  Gastrointestinal Endoscopy · 2020 · https://doi.org/10.1016/j.gie.2020.04.039

• ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

  Journal of Crohn s and Colitis · 2019 · https://doi.org/10.1093/ecco-jcc/jjz187

• ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

  Journal of Crohn s and Colitis · 2019 · https://doi.org/10.1093/ecco-jcc/jjz180

• Deep learning algorithms for automated detection of Crohn’s disease ulcers by video capsule endoscopy

  Gastrointestinal Endoscopy · 2019 · https://doi.org/10.1016/j.gie.2019.11.012

• ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

  Journal of Crohn s and Colitis · 2018 · https://doi.org/10.1093/ecco-jcc/jjy113

• Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

  Journal of Crohn s and Colitis · 2017 · https://doi.org/10.1093/ecco-jcc/jjx009

• Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases

  Clinical Gastroenterology and Hepatology · 2015 · https://doi.org/10.1016/j.cgh.2015.10.025

• Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial

  Clinical Gastroenterology and Hepatology · 2015 · https://doi.org/10.1016/j.cgh.2015.02.019

• Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab

  Clinical Gastroenterology and Hepatology · 2014 · https://doi.org/10.1016/j.cgh.2014.07.029

• The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab

  Gut · 2013 · https://doi.org/10.1136/gutjnl-2013-305259

• Optimizing anti-TNF treatments in inflammatory bowel disease

  Autoimmunity Reviews · 2013 · https://doi.org/10.1016/j.autrev.2013.06.002

• Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease

  Clinical Gastroenterology and Hepatology · 2012 · https://doi.org/10.1016/j.cgh.2012.10.020

• The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful

  Gut · 2010 · https://doi.org/10.1136/gut.2009.201533

Current projects

No projects listed.